Apol1 Mediated Kidney Disease clinical trials

Explore recruiting apol1 mediated kidney disease clinical trials.

Recruiting apol1 mediated kidney disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Apol1 Mediated Kidney Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label Phase 2 Study to Evaluate the Safety, Tolerability, and Effect on Albuminuria of MZE829 in Adults with Proteinuric Chronic Kidney Disease and the APOL1 High Risk Genotype

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Apol1 Mediated Kidney Disease trials by city

Apol1 Mediated Kidney Disease in Toronto Apol1 Mediated Kidney Disease in Vancouver Apol1 Mediated Kidney Disease in Montreal Apol1 Mediated Kidney Disease in Calgary Apol1 Mediated Kidney Disease in Edmonton Apol1 Mediated Kidney Disease in Ottawa Apol1 Mediated Kidney Disease in Winnipeg Apol1 Mediated Kidney Disease in Quebec City Apol1 Mediated Kidney Disease in Hamilton Apol1 Mediated Kidney Disease in Kitchener Apol1 Mediated Kidney Disease in London Apol1 Mediated Kidney Disease in Halifax Apol1 Mediated Kidney Disease in New York Apol1 Mediated Kidney Disease in Los Angeles Apol1 Mediated Kidney Disease in Chicago Apol1 Mediated Kidney Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease